Genomic analyses across six cancer types identify basal-like breast cancer as a unique molecular entity (Q35079683)

24384914

6 August 2017

title

Genomic analyses across six cancer types identify basal-like breast cancer as a unique molecular entity (English)

1 reference

24384914

ERRATUM: Genomic Analyses across Six Cancer Types Identify Basal-like Breast Cancer as a Unique Molecular Entity

6 August 2017

corrigendum / erratum

1 reference

12 July 2019

http://api.crossref.org/works?select=update-to&filter=doi:10.1038/SREP08179

author

Aleix Prat

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6506566&resulttype=core&format=json

14 May 2020

Vicente Peg

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6506566&resulttype=core&format=json

14 May 2020

Ana Vivancos

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6506566&resulttype=core&format=json

14 May 2020

Paolo Nuciforo

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6506566&resulttype=core&format=json

14 May 2020

Héctor G. Palmer

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6506566&resulttype=core&format=json

14 May 2020

Enriqueta Felip

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6506566&resulttype=core&format=json

14 May 2020

Javier Cortes

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6506566&resulttype=core&format=json

14 May 2020

Josep Tabernero Caturla

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6506566&resulttype=core&format=json

14 May 2020

10

Shaheenah Dawood

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6506566&resulttype=core&format=json

14 May 2020

Josep Maria Del Campo

13

object named as

Josep Maria Del Campo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6506566&resulttype=core&format=json

14 May 2020

author name string

Barbara Adamo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6506566&resulttype=core&format=json

14 May 2020

Cheng Fan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6506566&resulttype=core&format=json

14 May 2020

Maria Vidal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6506566&resulttype=core&format=json

14 May 2020

Patricia Galván

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6506566&resulttype=core&format=json

14 May 2020

Jordi Rodón

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6506566&resulttype=core&format=json

14 May 2020

Santiago Ramon y Cajal

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6506566&resulttype=core&format=json

14 May 2020

Javier Cortés

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6506566&resulttype=core&format=json

14 May 2020

language of work or name

English

0 references

publication date

18 December 2013

1 reference

6 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6506566&resulttype=core&format=json

14 May 2020

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6506566&resulttype=core&format=json

14 May 2020

page(s)

3544

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6506566&resulttype=core&format=json

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

14 May 2020

cites work

1 reference

Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer

21 January 2018

1 reference

Association of KRAS G13D tumor mutations with outcome in patients with metastatic colorectal cancer treated with first-line chemotherapy with or without cetuximab

21 January 2018

1 reference

Poly(ADP)-ribose polymerase inhibition: frequent durable responses in BRCA carrier ovarian cancer correlating with platinum-free interval

21 January 2018

1 reference

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

21 January 2018

1 reference

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

21 January 2018

1 reference

Integrated genomic analyses of ovarian carcinoma

21 January 2018

1 reference

Comprehensive molecular characterization of human colon and rectal cancer

21 January 2018

1 reference

Comprehensive genomic characterization of squamous cell lung cancers

21 January 2018

1 reference

The genomic landscape of breast cancer as a therapeutic roadmap

21 January 2018

1 reference

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

21 January 2018

1 reference

Phase II study of efficacy, safety, and pharmacokinetics of trastuzumab monotherapy administered on a 3-weekly schedule

21 January 2018

1 reference

What is principal component analysis?

21 January 2018

1 reference

ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking

21 January 2018

1 reference

Molecular classification of nonsmall cell lung cancer using a 4-protein quantitative assay

21 January 2018

1 reference

Building prognostic models for breast cancer patients using clinical variables and hundreds of gene expression signatures.

21 January 2018

1 reference

Gene expression patterns associated with p53 status in breast cancer.

21 January 2018

1 reference

Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer

21 January 2018

1 reference

Supervised risk predictor of breast cancer based on intrinsic subtypes

21 January 2018

1 reference

Diverse somatic mutation patterns and pathway alterations in human cancers

21 January 2018

1 reference

Mammary development meets cancer genomics.

21 January 2018

1 reference

Basal cytokeratins and their relationship to the cellular origin and functional classification of breast cancer

21 January 2018

1 reference

Basal-like breast cancer: a critical review

21 January 2018

1 reference

Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancer

21 January 2018

1 reference

BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells

21 January 2018

1 reference

Cancer cell of origin: spotlight on luminal progenitors

21 January 2018

1 reference

Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers

21 January 2018

1 reference

Cell of origin of lung cancer.

21 January 2018

1 reference

Cyclin E amplification/overexpression is a mechanism of trastuzumab resistance in HER2+ breast cancer patients

21 January 2018

1 reference

Genomic analysis identifies unique signatures predictive of brain, lung, and liver relapse.

21 January 2018

1 reference

Prognostic factors for survival of stage I nonsmall cell lung cancer patients : a population-based analysis of 19,702 stage I patients in the California Cancer Registry from 1989 to 2003.

21 January 2018

1 reference

Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer

21 January 2018

1 reference

Genomic predictors of response to doxorubicin versus docetaxel in primary breast cancer

21 January 2018

1 reference

Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistance

21 January 2018

1 reference

Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR.

21 January 2018

1 reference

Basal-like Breast cancer DNA copy number losses identify genes involved in genomic instability, response to therapy, and patient survival

21 January 2018

1 reference

HER2 in high-risk rectal cancer patients treated in EXPERT-C, a randomized phase II trial of neoadjuvant capecitabine and oxaliplatin (CAPOX) and chemoradiotherapy (CRT) with or without cetuximab

21 January 2018

1 reference

Molecular characterization of basal-like and non-basal-like triple-negative breast cancer

21 January 2018

1 reference

Combined targeting of the estrogen receptor and the epidermal growth factor receptor in non-small cell lung cancer shows enhanced antiproliferative effects.

21 January 2018

1 reference

Targeting aromatase and estrogen signaling in human non-small cell lung cancer

21 January 2018

1 reference

Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial

21 January 2018

1 reference

Bevacizumab: overview of the literature

21 January 2018

1 reference

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

21 January 2018

1 reference

A compact VEGF signature associated with distant metastases and poor outcomes

21 January 2018

1 reference

Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity.

21 January 2018

1 reference

Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes

21 January 2018

1 reference

Differential pathogenesis of lung adenocarcinoma subtypes involving sequence mutations, copy number, chromosomal instability, and methylation

21 January 2018

1 reference

Cluster analysis and display of genome-wide expression patterns

21 January 2018

1 reference

Molecular prescreening to select patient population in early clinical trials

21 January 2018

1 reference

Erratum: Integrated genomic analyses of ovarian carcinoma

21 January 2018

1 reference

21 January 2018

1 reference

WT1 is an integral component of an antibody panel to distinguish pancreaticobiliary and some ovarian epithelial neoplasms

21 January 2018

1 reference

12 December 2020

DAVID: Database for Annotation, Visualization, and Integrated Discovery

1 reference

12 December 2020

The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups

1 reference

12 December 2020

Comprehensive molecular portraits of human breast tumours

1 reference

12 December 2020

New approach to cancer therapy based on a molecularly defined cancer classification.

1 reference

12 December 2020

Identifiers

DOI

10.1038/SREP03544

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6506566&resulttype=core&format=json

Dimensions Publication ID

14 May 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6506566&resulttype=core&format=json

14 May 2020

24384914

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6506566&resulttype=core&format=json